Cryotherapy as a Coadjuvant in Crotaline Snakebite Management With Antivenom.

NACompletedINTERVENTIONAL
Enrollment

38

Participants

Timeline

Start Date

January 1, 2015

Primary Completion Date

July 1, 2017

Study Completion Date

July 1, 2017

Conditions
Snake Bites
Interventions
BIOLOGICAL

F(ab)2 antivenom therapy (antivipmyn®).

Antivipmyn is an equine origin antivenom produced by Institute Bioclon in Mexico (Silanes Laboratories, México). The snake venoms used to create the F(ab')2 fragments are from Crotalus durissus and Bothrops asper. The number of doses of each patient depended on the classification and evolution, as indicated by the manufacturer for grade II envenoming: from 6 to 10 bottles of F(ab)2 antivenom therapy, intravenously, as an initial dose. One dose (bottle) consisted of 10 mL of polyvalent concentrated and modified horse antibodies treated by enzymatic digestion to neutralize the Bothrops asper venom to not less than 780 lethal dose 50 (LD50), and the Crotalus basiliscus venom to not less than 790 LD50.

PROCEDURE

Local cryotherapy.

Interval cryotherapy consisted of applying a plastic bag (the size of the bag depending on the size of the lesion, approximately 28 x 46 cm) two-thirds filled with crushed ice (frapped) wrapped in a towel applied for 20 minutes every 4 hours at the site of the snakebite throughout the hospital stay. New ice bags were used after 4 hours.

All Listed Sponsors
lead

Hospital Juarez de Mexico

OTHER_GOV

NCT04470791 - Cryotherapy as a Coadjuvant in Crotaline Snakebite Management With Antivenom. | Biotech Hunter | Biotech Hunter